Search Results - "Blancafort, A"

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer by Oliveras, G., Blancafort, A., Urruticoechea, A., Campuzano, O., Gómez-Cabello, D., Brugada, R., López-Rodríguez, M. L., Colomer, R., Puig, T.

“…Fatty acid synthase (FASN) expression and activity has emerged as a common phenotype in most human carcinomas, including breast cancer, and its expression is…”
Get full text

DNA methylation signature to identify trastuzumab response in HER2 breast cancer models by Palomeras, S., Díaz Lagares, Á, Blancafort, A., Sarrats, A., Crujeiras Martinez, A.B., Sandoval, J., Rabionet, M., Welm, A.L., Esteller, M., Puig, T.

Get full text

Abstract P4-09-10: Prospective Analysis of Fatty Acid Synthase (FASN) in Breast Cancer Tissue of Early-Stage Breast Cancer Patients by Puig, T, Blancafort, A, Casoliva, G, Oliveras, G, Casas, M, Buxo, M, Saiz, E, Viñas, G, Dorca, J, Porta, R

“…Abstract Background: Cancer cells require nutrients to survive in the unfavorable microenvironment of primary solid tumors or metastases before angiogenesis…”
Get full text

Abstract P6-11-02: Inhibition of mTOR and Fatty Acid Synthase (FASN) overcome acquired resistance to Trastuzumab, Lapatinib and both in HER2+ breast cancer by Puig, T, Blancafort, A, Giro, A, Viqueira, A, Viñas, G, Massaguer, A, Carrion-Salip, D, Bolos, MV, Urruticoechea, A, Oliveras, G

“…Abstract Introduction: Resistance to dual biological blockade of HER2 positive breast cancer arises as a novel therapeutic challenge with high clinical…”
Get full text

Abstract P4-09-11: Fatty Acid Synthase (FASN) expression in Triple-Negative Breast Cancer by Viñas, G, Oliveras, G, Perez-Bueno, F, Giro, A, Blancafort, A, Puig-Vives, M, Marcos-Gragera, R, Dorca, J, Brunet, J, Puig, T

“…Abstract Background: In approximately 15–20% of patients with breast cancer, the tumors do not express estrogen receptor (ER), progesterone receptor (PR) and…”
Get full text